> LAMP2 / CD107b Protein LAMP2 / CD107b Protein
Lysosomal-associated membrane protein 2 / Cluster of Differentiation 107b
LAMP2 / CD107b Products
LAMP2 / CD107b Protein, Recombinant
| Molecule | Species | Description //For Detailed Info. and Price------CLICK! | Cat. No |
| LAMP2/CD107b | Mouse | LAMP2/CD107b Protein, Recombinant | 50791-M08H |
LAMP2 / CD107b cDNA Clone
| Molecule | Species | Description //For Detailed Info. and Price------CLICK! | Cat. No |
| LAMP2/CD107b | Mouse | Mouse LAMP2/CD107b cDNA Clone / ORF Clone | MG50791-G |
LAMP2 / CD107b Related Areas
Immunology>>Cluster of Differentiation>>Other>>LAMP2/CD107b
LAMP2 / CD107b Alternative Names
LAMP2, CD107b, LAMPB, LGP110 [Homo sapiens]
LAMP2, CD107b, RP23-193O17.2, Lamp-2, Lamp-2a, Lamp-2b, Lamp-2c, Mac3 [Mus musculus]
LAMP2 / CD107b Background
LAMP2 (Lysosomal-associated membrane protein 2), also known as CD107b (Cluster of Differentiation 107b), is a member of a family of membrane glycoproteins. This glycoprotein provides selectins with carbohydrate ligands. In human, LAMP2, the causative gene of Danon disease, located on chromosome Xq24, encodes the lysosome-associated membrane protein-2 (LAMP-2). LAMP-2 deficiency, or Danon disease, is a rare X-linked lysosomal disease characterized by cardiomyopathy, vacuolar myopathy, and mental retardation. LAMP2 cardiomyopathy is an X-linked and highly progressive myocardial storage disorder associated with diminished survival, which clinically resembles sarcomeric hypertrophic cardiomyopathy.
LAMP2 / CD107b Related Studies
- Maron BJ, et al. (2010) Profound left ventricular remodeling associated with LAMP2 cardiomyopathy. Am J Cardiol. 106(8): 1194-6.
- Di Blasi C, et al. (2008) Danon disease: a novel LAMP2 mutation affecting the pre-mRNA splicing and causing aberrant transcripts and partial protein expression. Neuromuscul Disord. 18(12): 962-6.
- Echaniz-Laguna A, et al. (2006) Novel Lamp-2 gene mutation and successful treatment with heart transplantation in a large family with Danon disease. Muscle Nerve. 33(3): 393-7.
+86-400-890-9989



